In a study performed in the UK researchers explored how men with advanced prostate cancer support their personal well being. The study analyzed the practices used by five (5) men with advanced prostate cancer to maintain their emotional wellbeing. Information about the men’s individual practices was taken from face-to-face, semi-structured, in-depth interviews with the five [...]
In a presentation at the ASCO Annual Meeting, Dr. Andrew Himelstein, MD, FACP of the Helen F. Graham Cancer Center & Research Institute, presented the results of a trial evaluating Zoledronic Acid (Zometa) at a dosing schedule of every 12 weeks as opposed to the current standard of care of every 4 weeks. The trial included [...]
About one hour ago I received some good news from Zero pertaining to the Congressionally Directed Medical Research Program. The HAC-D report of the FY2016 Defense Appropriations Bill has the Prostate Cancer Research Program funded at $80M. The full bill can be seen here : http://appropriations.house.gov/uploadedfiles/hrpt-114-hr-fy2016-defense.pdf and the CDMRP numbers are found on page 273. The [...]
According to a news release from MD Anderson they have recently completed a study that shows that combining two separate chemotherapy agents is more effective than sequencing them one after another. The current standard of care for the cytotoxic chemotherapy agents used to treat prostate cancer is to treat men with advanced metastatic castration-resistant prostate [...]
Starting androgen deprivation therapy (ADT) to treat advanced prostate cancer is usually the start of a long treatment period that will continue for many years, actually until you die. Since our goal in cancer treatment is to make cancer a chronic illness and since prostate cancer does progress for most men in a relatively slow [...]